Literature DB >> 7717777

The Whipple resection for cancer in U.S. Department of Veterans Affairs Hospitals.

T P Wade1, A G el-Ghazzawy, K S Virgo, F E Johnson.   

Abstract

OBJECTIVE: The authors compiled the results after Whipple resection for cancer from a large U.S. national hospital system.
METHODS: Computerized hospital and death benefits records for patients treated with Whipple resection for cancer from 1987 to 1991 in U.S. Department of Veterans Affairs hospitals were analyzed, excluding lymphomas and neuroendocrine tumors. Institutional tumor registrar reports allowed TNM staging in 45% of these cancers.
RESULTS: Whipple resections were performed in 252 patients with pancreatic cancer and 117 with other periampullary cancers. Complications occurred in 37%, and 30-day operative mortality was 8%. Postoperative sepsis was associated with a higher operative mortality rate. In patients with staged tumors, 5-year survivors were found only in those without lymph node involvement.
CONCLUSIONS: Whipple resection can cure cancer in or near the head of the pancreas when lymph nodes are not invaded by tumor. Complications occur in nearly 40% of patients, whereas operative mortality rate is related to the average age of the patient population.

Entities:  

Mesh:

Year:  1995        PMID: 7717777      PMCID: PMC1234565          DOI: 10.1097/00000658-199503000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

1.  Pancreaticoduodenectomy for Islet Carcinoma : A Five-Year Follow-Up.

Authors:  A O Whipple
Journal:  Ann Surg       Date:  1945-06       Impact factor: 12.969

2.  Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality.

Authors:  M Trede; G Schwall; H D Saeger
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

3.  Aging veterans: will they overwhelm the VA medical care system?

Authors:  C Horgan; A Taylor; G Wilensky
Journal:  Health Aff (Millwood)       Date:  1983       Impact factor: 6.301

4.  Current status of pancreaticoduodenectomy for periampullary carcinoma.

Authors:  D W Crist; J L Cameron
Journal:  Hepatogastroenterology       Date:  1989-12

5.  Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?

Authors:  H A Pitt; A S Gomes; J F Lois; L L Mann; L S Deutsch; W P Longmire
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

6.  Pyloric and gastric preserving pancreatic resection. Experience with 87 patients.

Authors:  J W Braasch; D J Deziel; R L Rossi; E Watkins; P F Winter
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

7.  A reappraisal of total pancreatectomy for pancreatic cancer: results from U.S. Veterans Affairs hospitals, 1987-1991.

Authors:  T J Swope; T P Wade; T J Neuberger; K S Virgo; F E Johnson
Journal:  Am J Surg       Date:  1994-12       Impact factor: 2.565

8.  Decreased morbidity and mortality after pancreatoduodenectomy.

Authors:  P A Grace; H A Pitt; R K Tompkins; L DenBesten; W P Longmire
Journal:  Am J Surg       Date:  1986-01       Impact factor: 2.565

9.  An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy.

Authors:  C A Pellegrini; C F Heck; S Raper; L W Way
Journal:  Arch Surg       Date:  1989-07

10.  Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery.

Authors:  H Baumel; M Huguier; J C Manderscheid; J M Fabre; S Houry; H Fagot
Journal:  Br J Surg       Date:  1994-01       Impact factor: 6.939

View more
  20 in total

1.  Emergency pancreaticoduodenectomy with delayed reconstruction for bleeding: a life saving procedure.

Authors:  J J Tuech; P Pessaux; N Regenet; R Bergamaschi; J P Arnaud
Journal:  Int J Pancreatol       Date:  2001

2.  How to pass on expertise: pancreatoduodenectomy at a teaching hospital.

Authors:  Peter Wamser; Anton Stift; Christian Passler; Peter Goetzinger; Thomas Sautner; Raimund Jakesz; Reinhold Fuegger
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

3.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

4.  "Practice makes perfect" is intuitive; the applicability of this axiom to surgical outcomes has been tenuous at best.

Authors:  T P Wade; F E Johnson
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

5.  Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

Authors:  K D Lillemoe; J L Cameron; C J Yeo; T A Sohn; A Nakeeb; P K Sauter; R H Hruban; R A Abrams; H A Pitt
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

6.  Hemorrhage after pancreatoduodenectomy.

Authors:  B Rumstadt; M Schwab; P Korth; M Samman; M Trede
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

7.  Omental flap in pancreaticoduodenectomy for protection of splanchnic vessels.

Authors:  Atsuyuki Maeda; Tomoki Ebata; Hideyuki Kanemoto; Kazuya Matsunaga; Etsuro Bando; Shigeki Yamaguchi; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

8.  Prognosis and feasibility of en-bloc vascular resection in stage II pancreatic adenocarcinoma.

Authors:  K Dilip Chakravarty; Jun-Te Hsu; Keng-Hao Liu; Chun-Nan Yeh; Ta-Sen Yeh; Tsann-Long Hwang; Yi-Yin Jan; Miin-Fu Chen
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 9.  Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.

Authors:  Markus Schäfer; Beat Müllhaupt; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

10.  A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma.

Authors:  Russell Lewis; Jeffrey A Drebin; Mark P Callery; Douglas Fraker; Tara S Kent; Jenna Gates; Charles M Vollmer
Journal:  HPB (Oxford)       Date:  2012-09-24       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.